Mode
Text Size
Log in / Sign up

Early preterm birth linked to lower atopic dermatitis risk in large meta-analysisPreterm birth linked to lower allergy risk in children

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider gestational age as a factor in allergy risk assessment, but interpret associations cautiously due to observational data.

This meta-analysis of observational studies examined the association between gestational age at birth and the risk of atopic dermatitis (AD) and allergic rhinitis (AR) in children. The analysis included data from over 5 million newborns and children. The primary outcome was the risk of developing AD and AR based on gestational age categories: early preterm, preterm, and post-term compared to full-term birth.

The authors found that early preterm birth was associated with a reduced risk of AD, and preterm birth also showed a reduced risk. In contrast, post-term birth was associated with an increased risk of AD. For AR, early preterm birth was suggestively associated with a reduced risk. All results were reported as odds ratios with confidence intervals.

Key limitations include the observational nature of the included studies, which precludes establishing causality. The authors note that subgroup and sensitivity analyses were performed, but specific limitations were not detailed in the abstract. The findings highlight the perinatal period as a critical window for allergy risk stratification and early prevention strategies.

Clinicians should interpret these associations cautiously, recognizing that the absolute risk differences are not reported and that confounding factors may influence the results. The study underscores the need for further research to understand the underlying mechanisms.

A new analysis of more than 5 million children suggests that being born early may be linked to a lower risk of developing two common allergic conditions: atopic dermatitis (eczema) and allergic rhinitis (hay fever). However, the study only shows an association, not cause and effect, and the findings should not change how parents or doctors think about preterm birth.

Researchers combined data from multiple observational studies that followed newborns and children over time. The analysis included nearly 5.4 million participants. The team looked at how gestational age at birth (how early or late a baby is born) related to the chances of developing eczema or hay fever later in childhood.

The results showed that children born early preterm (before 34 weeks) had about 25% lower odds of developing eczema compared to full-term babies. For all preterm births (before 37 weeks), the odds were about 14% lower. On the other hand, babies born post-term (after 42 weeks) had slightly higher odds of eczema, about 8% higher. For hay fever, early preterm birth was linked to about 16% lower odds, though the researchers described this finding as "suggestive" rather than conclusive.

No safety concerns were reported in this analysis, as it did not test any treatment or intervention. The study only looked at existing data on birth timing and allergy outcomes.

It is important to understand the limitations of this research. Because the studies were observational, they can only show links, not prove that being born early causes a lower allergy risk. Other factors, such as genetics, environment, or breastfeeding, could explain the results. The researchers also did not report absolute risk numbers, meaning we do not know the actual chance of developing allergies for any group. The association for hay fever was described as "suggestive," meaning it is less certain.

For patients and parents, this study does not change current medical advice. Preterm birth carries many health risks, and these findings should not be interpreted as a reason to aim for early delivery. The results do highlight that the period around birth may be important for allergy development, but more research is needed before any practical recommendations can be made.

What this means for you:
Preterm birth is linked to lower allergy risk, but this does not mean early delivery is beneficial.

Study Details

Study typeMeta analysis
Sample sizen = 5,410,969
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: The perinatal period has been postulated to be a window of opportunities in preventing atopic disorders. Accumulating studies suggested that an association exists between gestational age (GA) and allergic diseases. METHODS: The meta-analysis of observational studies was conducted through a search of relevant literature until 31 December 2023 from PubMed, Embase, and Web of Science databases. Subgroup analyses and sensitivity analyses were performed to test the robustness and consistency of the observed associations. RESULTS: Thirty observational studies comprising 5,410,969 participants were included in the meta-analysis. The pooled estimates (odds ratio [OR]) of atopic dermatitis (AD) risk for early preterm, preterm and post-term birth were 0.75 (95% confidence interval [CI]: 0.68-0.82), 0.86 (95% CI: 0.81-0.93), 1.08 (95% CI: 1.03-1.14), respectively. Additionally, early preterm birth was suggestively associated with reduced risk of allergic rhinitis (AR) (OR: 0.84, 95% CI: 0.73-0.97). CONCLUSION: Our study demonstrated that early preterm and preterm births were associated with a reduced risk of AD, while post-term birth was linked to an increased risk, with early preterm birth also suggestively associated with a reduced risk of AR. IMPACT: This large-scale meta-analysis demonstrates that early preterm and preterm births are associated with a significantly reduced risk of atopic dermatitis (AD), while post-term birth is linked to an increased risk. Early preterm birth is also suggestively associated with a lower risk of allergic rhinitis (AR), highlighting the nuanced role of gestational age in the development of allergic diseases. These findings underscore the importance of the perinatal period as a critical window for allergy risk stratification and early prevention strategies in pediatric populations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.